Heplisav B Den europeiske union - norsk - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - hepatitt b overflate antigen - hepatitt b - vaksiner - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Innovax-ILT Den europeiske union - norsk - EMA (European Medicines Agency)

innovax-ilt

intervet international b.v. - cell-assosiert levende rekombinant kalkunherpesvirus (stamme hvt / ilt-138), som uttrykker glykoproteinene gd og gi av infeksiøst laryngotrakeittvirus - immunologicals for aves, live viral vaksiner - kylling - for aktiv immunisering av en dag gamle kyllinger for å redusere dødelighet, kliniske tegn og lesjoner på grunn av infeksjon med aviær infeksiøs laryngotracheitt (ilt) virus og mareks sykdom (md) virus.

Innovax-ND-IBD Den europeiske union - norsk - EMA (European Medicines Agency)

innovax-nd-ibd

intervet international b.v. - celle-forbundet live rekombinant tyrkia herpes-virus (belastning hvp360), uttrykker fusion protein av nd-virus og vp2 protein av ibd virus - avian herpes virus (marek ' s sykdom) + avian smittsomme bursal disease virus (gumboro sykdom) + newcastle disease virus/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Synalar 0.025 % Norge - norsk - Statens legemiddelverk

synalar 0.025 %

bioglan ab - fluocinolonacetonid - krem - 0.025 %

Synalar 0.025 % Norge - norsk - Statens legemiddelverk

synalar 0.025 %

bioglan ab - fluocinolonacetonid - gel - 0.025 %

Synalar 0.025 % Norge - norsk - Statens legemiddelverk

synalar 0.025 %

bioglan ab - fluocinolonacetonid - salve - 0.025 %

Synalar med Chinoform 0.25 mg/ g / 30 mg/ g Norge - norsk - Statens legemiddelverk

synalar med chinoform 0.25 mg/ g / 30 mg/ g

bioglan ab - fluocinolonacetonid / kliokinol - krem - 0.25 mg/ g / 30 mg/ g

Innovax-ND-ILT Den europeiske union - norsk - EMA (European Medicines Agency)

innovax-nd-ilt

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals for aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Visudyne Den europeiske union - norsk - EMA (European Medicines Agency)

visudyne

cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - Øyemidler - visudyne er angitt for behandling av:voksne med exudative (våt) aldersrelatert makuladegenerasjon (amd) med overveiende klassisk subfoveal choroidal neovascularisation (cnv) eller;voksne med subfoveal choroidal neovascularisation sekundær til patologisk myopi.

Nephromag 0.2 mg/2.5 ml Norge - norsk - Statens legemiddelverk

nephromag 0.2 mg/2.5 ml

rotop pharmaka gmbh - mertiatid - preparasjonssett til radioaktive legemidler - 0.2 mg/2.5 ml